(Q53596582)

16 May 2018

title

Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil. (English)

1 reference

16 May 2018

1 reference

1 reference

1 reference

Jun Guo

1

1 reference

16 May 2018

An-wu Zhou

2

1 reference

16 May 2018

Yu-cai Fu

3

1 reference

16 May 2018

Udit N Verma

4

1 reference

16 May 2018

Debu Tripathy

5

1 reference

16 May 2018

Eugene P Frenkel

6

1 reference

16 May 2018

Carlos R Becerra

7

1 reference

16 May 2018

publication date

1 October 2006

1 reference

16 May 2018

Acta Pharmacologica Sinica

published in

1 reference

16 May 2018

volume

27

1 reference

16 May 2018

issue

10

1 reference

16 May 2018

page(s)

1375-1381

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2006.00421.x

exact match

0 references

cites work

Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00421.X

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00421.X

Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00421.X

Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00421.X

Capecitabine: a novel agent for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00421.X

10.1111/J.1745-7254.2006.00421.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

Dimensions Publication ID

0 references

1 reference

16 May 2018